HLAssure SE SBT Kits is now China FDA approved

TBG Biotechnology

Media Partnering

Language

English

繁體中文

简体中文

Reagents

SSP Typing Kits SBT Typing Kits Real Time PCR Typing Kits

Nucleic Acid Extraction Kits Illumina Based NGS Typing Kits Nanopore Based TGS Typing Kits Analysis Software
Equipments

Nucleic Acid Extraction Systems Automated Pipetting System Real Time PCR System
Service

HLA Genotyping Manufacturing
Research & Development

Benefits of Molecular Diagnostics Sequence Specific Primers Sequencing Based Typing

Links to Resources Developing Products
About TBG

Company Introduction Our Vision Our Board of Directors

Career Opportunities Quality systems

Contact us
Investor Center

Financial Reports Research

Presentations Company Announcements Corporate Governance

Home / Media / News and Update / Detail

Media

News and Update

01.Nov
2017

HLAssure SE SBT Kits is now China FDA approved

As of October 23rd, 2017. TBG's HLAssure SE SBT Kits received the China CFDA approval for clinical use. This is the first approval for a High Resolution HLA Typing Kit in China. Please see our ASX announcements for further details or contact your local TBG staff for questions.

Media

News and Update

HLAssure SE SBT Kits is now China FDA approved

Copyright © 2004 ~ 2020 TBG Diagnostics Limited. All rights reserved. powered by rIDEA